S.2665 - A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.115th Congress (2017-2018)
|Sponsor:||Sen. Young, Todd C. [R-IN] (Introduced 04/12/2018)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 04/12/2018 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2665 — 115th Congress (2017-2018)All Information (Except Text)
A summary is in progress.